A San Jose company that does molecular diagnostics has just closed a huge Series C investment round of $52.7M. They are going to use the infusion of cash to develop prenatal tests that will determine whether or not unborn children have certain trisomies, such as one associated with Down syndrome.
It's also nice to see some companies outside of the greentech industry get funded in San Jose!
Source: SJBJ
No comments:
Post a Comment